Skip to main content
Caplight Logo









Symbionic

Symbionic

Private
ChennaiHealthcare & Life Scienceshttps://www.symbionic.co/

Last Round

Strategic

Mar 19, 2025

Est. Valuation

$4.8M

Total Funding Raised

$916,000

Company Overview

Symbionic is an assistive technology company that designs and manufactures affordable, modular bionic prosthetic arms for upper-limb amputees.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT

Business Model

B2C

Customer Profile

Hardware Sales

AI Layer

Application

Keywords

bionic armprosthetic deviceassistive technologyupper-limb prosthesisbionicsmyoelectric prosthesismedical hardwareEMG sensorspattern recognitionmodular prosthesissmart prosthesisaffordable healthcaremedtechprosthetic hand

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Symbionic Comparables

Compare Symbionic with similar companies based on industry and business-model similarity.

Symbionic comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Makers Hive Innovations
90%
Symbica Private Limited
88%
Robo Bionics
86%

Symbionic Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicMar 19, 2025
GrantMar 19, 2025
SeedJun 16, 2023
GrantDec 5, 2022
Pre SeedMar 1, 2021

Key People

Founding team and executive leadership

Rishi Krishna

CEO & Co-Founder

Founding Team

Niranjan kumar

Chief Technology Officer

Executive Team

Symbionic Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 1, 2025

    Monthly visitors increased 30% MoM, reaching 12.9K.

  • Dec 5, 2022

    $15K round from Singapore International Foundation

Symbionic Filings

Explore SEC and related filing metadata, where available.

Symbionic filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Symbionic's valuation, stock price, and market status.

Is Symbionic a public or private company?

Symbionic is a private company.

What is the current stock price of Symbionic?

Symbionic is a private company with no public stock price. No recent secondary market data is available.

How much is Symbionic worth (valuation)?

Symbionic's valuation is estimated at $4.8M based on funding round data.

Can I buy Symbionic stock?

Symbionic shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Symbionic's last funding round?

Symbionic's most recent funding round was Strategic on March 19, 2025.

Who are the main investors in Symbionic?

Key investors in Symbionic include Biotechnology Industry Research Assistance Council, Mudhal Partners, Singapore International Foundation.

Will Symbionic IPO soon?

No public IPO plans have been announced for Symbionic.

How can I track Symbionic secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Symbionic's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersChennai
Employee Range15
Year Founded2019
Last FundingMar 19, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?